These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2483484)

  • 1. [The general and specific properties of Neisseria meningitidis lipopolysaccharide compared to the lipopolysaccharides of other gram-negative bacteria].
    Stukalova NV; Aleksakhina NN; Basnak'ian IA
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Dec; (12):81-7. PubMed ID: 2483484
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15 Suppl 2():S76-84. PubMed ID: 2440812
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].
    Rietschel ET; Brade H
    Infection; 1987; 15(2):133-41. PubMed ID: 2439461
    [No Abstract]   [Full Text] [Related]  

  • 4. The R-type lipopolysaccharides of Neisseria meningitidis.
    Jennings HJ; Bhattacharjee AK; Kenne L; Kenny CP; Calver G
    Can J Biochem; 1980 Feb; 58(2):128-36. PubMed ID: 6155984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins.
    Zollinger WD; Mandrell RE
    Infect Immun; 1980 May; 28(2):451-8. PubMed ID: 6156902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against Neisseria meningitidis lipopolysaccharide.
    Sugasawara RJ; Prato C; Sippel JE
    Infect Immun; 1983 Dec; 42(3):863-8. PubMed ID: 6417025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-specific antigens of Neisseria meningitidis serogroup A.
    Di Ninno VL; Chenier VK; Bhatti AR; White LA
    J Clin Microbiol; 1982 Mar; 15(3):379-83. PubMed ID: 6176593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.
    Frasch CE; Zollinger WD; Poolman JT
    Rev Infect Dis; 1985; 7(4):504-10. PubMed ID: 2412271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.
    Zollinger WD; Mandrell RE
    Infect Immun; 1977 Nov; 18(2):424-33. PubMed ID: 72735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide-derived serotype polysaccharides from Neisseria meningitidis group B.
    Apicella MA
    J Infect Dis; 1979 Jul; 140(1):62-72. PubMed ID: 88491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
    J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the capsular antigen of Neisseria meningitidis serogroup K.
    Van der Kaaden A; Gerwig GJ; Kamerling JP; Vliegenthart JF; Tiesjema RH
    Eur J Biochem; 1985 Nov; 152(3):663-8. PubMed ID: 3932071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipopolysaccharide of gram-negative bacilli in sensitivity and resistance to serum.
    Porat R; Johns MA; McCabe WR
    Prog Clin Biol Res; 1988; 272():103-14. PubMed ID: 2455915
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure and immunochemistry of meningococcal lipopolysaccharides.
    Jennings HJ; Beurret M; Gamian A; Michon F
    Antonie Van Leeuwenhoek; 1987; 53(6):519-22. PubMed ID: 3130788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production, characterization and biological effects of monoclonal antibodies to different parts of the gram-negative lipopolysaccharide core region.
    Appelmelk BJ; Verweij-van Vught M; Brade H; Maaskant J; Schouten W; Thijs B; MacLaren D
    Prog Clin Biol Res; 1988; 272():373-82. PubMed ID: 2455918
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic potential of a highly conserved Neisseria meningitidis lipopolysaccharide inner core structure defined by chemical synthesis.
    Reinhardt A; Yang Y; Claus H; Pereira CL; Cox AD; Vogel U; Anish C; Seeberger PH
    Chem Biol; 2015 Jan; 22(1):38-49. PubMed ID: 25601073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine development targeting lipopolysaccharide structure modification.
    Zhao Y; Arce-Gorvel V; Conde-Álvarez R; Moriyon I; Gorvel JP
    Microbes Infect; 2018; 20(9-10):455-460. PubMed ID: 29233768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A.
    Achtman M; Kusecek B; Morelli G; Eickmann K; Wang JF; Crowe B; Wall RA; Hassan-King M; Moore PS; Zollinger W
    J Infect Dis; 1992 Jan; 165(1):53-68. PubMed ID: 1370175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies.
    Scholten RJ; Kuipers B; Valkenburg HA; Dankert J; Zollinger WD; Poolman JT
    J Med Microbiol; 1994 Oct; 41(4):236-43. PubMed ID: 7523677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological value of lipopolysaccharide and heat-modifiable outer-membrane protein serotyping of group-A strains of Neisseria meningitidis.
    Griffiss JM
    J Med Microbiol; 1982 Aug; 15(3):327-30. PubMed ID: 6811746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.